CryoSave
CryoSave South Africa is a Pretoria-based stem cell bank that collects, processes, and cryogenically stores umbilical cord blood and tissue from newborns and adult-derived stem cells from fatty tissues, serving expectant parents and families through a subscription-based, sales-led model with flexible payment plans.
- Company typePrivate
- Founded-
- HeadquartersPretoria, South Africa
- Headcount11–50
- GTM typeB2C
- OfferingServices
What CryoSave does
CryoSave South Africa (Pty) Ltd is a private biotechnology company headquartered in Pretoria, South Africa, that specializes in stem cell banking, cord blood processing, and tissue engineering for both newborns and adults. Its core offering is the cryogenic collection, processing, and long-term storage of stem cells harvested from umbilical cord blood and tissue at birth, with a secondary service line for adult stem cells derived from fatty tissues through approved medical partners. The company operates a state-of-the-art laboratory with professionally trained staff and holds AABB international accreditation (since 2017), a SAHPRA license, and Department of Health authorization, positioning it as a fully regulated and accredited stem cell bank in the South African market.
The business operates on a subscription-based recurring revenue model, where families pay for the collection, processing, and multi-year storage of stem cells, with personalized payment plans offered to accommodate individual financial circumstances. Go-to-market is sales-led, targeting expectant parents through a direct-to-consumer website with quote-request CTAs, baby exhibits, customer testimonials, and educational content anchored by its Medical Director (Dr. Peter Koll). Channel partnerships with medical aid funds (Momentum Multiply, CAMAF) and industry associations (Cord Blood Association, Parents Guide Cord Blood) extend cryosave's reach into insurance and healthcare ecosystems.
Strategic positioning is premised on regulatory credibility, brand association (claiming part of a global network serving more than 5 million families) and flexible payment options. The company is described as being "Powered by Aluma Capital," though the exact nature of this relationship (parent, investor, or technology partner) is not disclosed. The firm operates exclusively in South Africa with no disclosed expansion into additional geographies, and there is no disclosed funding, M&A activity, or patent portfolio in the available data.
CryoSave firmographics
Firmographics- Name
- CryoSave
- Legal name
- CryoSave South Africa (Pty) Ltd
- Website
- https://cryosave.co.za
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- CryoSave South Africa is a Pretoria-based stem cell bank that collects, processes, and cryogenically stores umbilical cord blood and tissue from newborns and adult-derived stem cells from fatty tissues, serving expectant parents and families through a subscription-based, sales-led model with flexible payment plans.
- Ownership category
- akta.pro rank
CryoSave industry classification
Industry- Product category
- Stem Cell Banking
- NAICS
- Blood and Organ Banks (621991)
- SIC
- Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)
- akta.pro secondary industries
- Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low) (HLAGAGAK), Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats) (HLAGAIAJ)
Keywords
Where CryoSave is headquartered
LocationHeadquarters
- HQ city
- Pretoria
- HQ country
- South Africa
- HQ region
- Africa
Offices1 record
Markets served
CryoSave business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D
Revenue model
- Stem Cell Banking Services: CryoSave generates revenue through stem cell banking services, charging families for the collection, processing, and long-term storage of stem cells. The company offers flexible payment plans personalized to customer financial needs.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels5 records
CryoSave product offering
Product offeringCore offering
CryoSave collects, processes, and cryogenically stores stem cells for newborns (from umbilical cord blood and tissue) and for adults and older children (from fatty tissues via approved medical partners). The company sells long-term stem cell banking subscriptions to expectant parents, families, and adults, with flexible personalized payment plans.
Product overview
CryoSave is a stem cell banking company operating in South Africa, offering two primary services: Newborn Stem Cell Storage (preserving umbilical cord blood and tissue stem cells at birth) and Adult Stem Cell Storage (storing stem cells derived from fatty tissues). The company positions itself as SA's Premier Stem Cell Bank, serving newborns, adults, and families with flexible payment options.
Differentiator
Problem solved
Functional benefit
Products and services
- Newborn Stem Cell Storage Storage service that preserves a newborn's umbilical cord blood and tissue stem cells collected at birth, intended for potential future regenerative or therapeutic medical use. Targeted at expectant parents and families.
- Adult Stem Cell Storage Storage service for stem cells derived from fatty tissues of adults and older children, collected through CryoSave's approved medical partners, intended for potential future therapeutic or regenerative medical use.
Quantifiable outcome
- More than 5 million families worldwide trust CryoSave for stem cell banking
Companies that use CryoSave
Customer profileNamed customers7 records
Segments3 records
Ideal customer profiles2 records
CryoSave technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
CryoSave partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered minor and core.
- Parents Guide Cord BloodminorPartner organization providing educational resources and marketing support for cord blood awareness and stem cell banking services.
- Cord Blood AssociationcoreIndustry association partner for cord blood standards and best practices in stem cell banking.
- Momentum MultiplyminorHealth and wellness partner offering integrated services for members seeking stem cell banking.
- CAMAFminorMedical aid fund partner providing stem cell banking options for members.
- Angelic KeepsakesminorPartner for keepsake and memory products complementing the birth and stem cell banking experience.
Scale indicators1 record
Recent moves6 records
Expansion highlights5 records
CryoSave competitors and assessment
Company assessmentDirect peers
- Cells4Life: UK-based private cord blood and tissue bank with whole blood storage options. Closely comparable service model targeting expectant parents with multi-decade storage contracts.
- Cord Blood Registry (CBR): Largest private cord blood bank in the United States, offering newborn cord blood and cord tissue cryopreservation with similar subscription-based long-term storage model. Closest functional peer to CryoSave's core service offering.
- FamilyCord: US-based private cord blood bank offering cord blood and cord tissue cryopreservation. Direct competitor serving the same expectant parent segment with similar long-term storage subscription model.
- Smart Cells International: UK-based private stem cell bank offering cord blood and tissue storage. Direct peer with similar positioning as a niche private bank targeting the same expectant parent customer segment.
- Americord Registry: US-based private cord blood bank with direct-to-consumer sales model. Comparable newer-generation private stem cell bank targeting expectant parents with similar service bundles.
- ViaCord: Established US cord blood and tissue banking service (formerly part of PerkinElmer, now Revvity). Direct competitor offering newborn stem cell collection, processing, and long-term cryogenic storage with comparable value proposition.
- StemCyte: Hybrid public/private cord blood bank operating internationally including Asia and the Middle East. Comparable umbilical cord blood and tissue banking services with established regulatory credentials.
- Cryo-Cell International: US-based public company offering private cord blood and menstrual stem cell banking services. Direct competitor in the consumer-facing stem cell banking space with similar recurring revenue model.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
CryoSave social profiles
Digital presenceCryoSave financial estimates
Financial estimateRevenue estimate
Valuation estimate
CryoSave leadership team
Management profileNumber of profiles
Profiles1 record
CryoSave funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
CryoSave M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about CryoSave
What does CryoSave do?
CryoSave collects, processes, and cryogenically stores stem cells for newborns (from umbilical cord blood and tissue) and for adults and older children (from fatty tissues via approved medical partners). The company sells long-term stem cell banking subscriptions to expectant parents, families, and adults, with flexible personalized payment plans.
Is CryoSave a public or private company?
CryoSave is a private company. It is classified as unknown and is currently operating.
When was CryoSave founded?
CryoSave was founded in -1. It employs 11 to 50 people.
Where is CryoSave based?
CryoSave is headquartered in Pretoria, South Africa, in the Africa region.
How does CryoSave make money?
One revenue line is on record: stem Cell Banking Services.
Who are CryoSave's main competitors?
Direct peers on record are Cells4Life, Cord Blood Registry (CBR), FamilyCord, Smart Cells International, Americord Registry, ViaCord, StemCyte and Cryo-Cell International.
Does CryoSave have an API?
No public API is recorded for CryoSave.
What industry is CryoSave in?
CryoSave's product category is Stem Cell Banking. Its primary akta.pro industry code is HLAAAGAE, Cell & Tissue Banking (biobanking, cord blood/tissue), with a secondary code of HLAGAGAK, Cold Chain Storage & Cryopreservation Services (LN2/Ultra-low). Its NAICS code is 621991 and its SIC code is 2836.